3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Activella®: new trials by email Literature Review of Activella® trials Research Report on Activella®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids Elagolix, Placebo, Estradiol/Norethindrone acetate (E2/NETA) - Heavy Uterine Bleeding, Uterine Fibroids | Phase 2 | Completed | AbbVie (prior sponsor, Abbott) | 271 | 2011-09-08 | 2021-07-13 |
| Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions Estradiol/Norethindrone acetate, Activella® - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 36 | 2007-02-01 | 2010-12-17 |
| Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions Estradiol/Norethindrone acetate, Activella® - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 40 | 2007-01-01 | 2010-12-08 |
Leiomyoma (1) · Menorrhagia (1)
Teva Pharmaceuticals USA (2) · AbbVie (prior sponsor, Abbott) (1)
Canada (2)
Paul Y Tam, M.D., F.R.C.P., F.A.C.P. (2)